Cargando…

Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette–Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus

We report a case of occult Mycobacterium bovis left axillary-bifemoral bypass graft infection, with superimposed acute methicillin-susceptible Staphylococcus aureus (MSSA) infection in an 82 year old male following intravesicular bacillus Calmette–Guerin (BCG) for adjuvant therapy of urothelial canc...

Descripción completa

Detalles Bibliográficos
Autores principales: DeSimone, Daniel C., Tande, Aaron J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850222/
https://www.ncbi.nlm.nih.gov/pubmed/31723689
http://dx.doi.org/10.1016/j.jctube.2016.09.001
_version_ 1783469377626046464
author DeSimone, Daniel C.
Tande, Aaron J.
author_facet DeSimone, Daniel C.
Tande, Aaron J.
author_sort DeSimone, Daniel C.
collection PubMed
description We report a case of occult Mycobacterium bovis left axillary-bifemoral bypass graft infection, with superimposed acute methicillin-susceptible Staphylococcus aureus (MSSA) infection in an 82 year old male following intravesicular bacillus Calmette–Guerin (BCG) for adjuvant therapy of urothelial cancer. The patient underwent partial removal of the bypass graft and treated with antimycobacterial therapy—rifampin and isoniazid for 9 months, and intravenous cefazolin followed by oral cephalexin for chronic suppressive therapy for MSSA. This presentation highlights the need to consider indolent infection masquerading as mechanical erosion, even when an alternate infection is present.
format Online
Article
Text
id pubmed-6850222
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68502222019-11-13 Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette–Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus DeSimone, Daniel C. Tande, Aaron J. J Clin Tuberc Other Mycobact Dis Article We report a case of occult Mycobacterium bovis left axillary-bifemoral bypass graft infection, with superimposed acute methicillin-susceptible Staphylococcus aureus (MSSA) infection in an 82 year old male following intravesicular bacillus Calmette–Guerin (BCG) for adjuvant therapy of urothelial cancer. The patient underwent partial removal of the bypass graft and treated with antimycobacterial therapy—rifampin and isoniazid for 9 months, and intravenous cefazolin followed by oral cephalexin for chronic suppressive therapy for MSSA. This presentation highlights the need to consider indolent infection masquerading as mechanical erosion, even when an alternate infection is present. Elsevier 2016-09-16 /pmc/articles/PMC6850222/ /pubmed/31723689 http://dx.doi.org/10.1016/j.jctube.2016.09.001 Text en © 2016 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
DeSimone, Daniel C.
Tande, Aaron J.
Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette–Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus
title Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette–Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus
title_full Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette–Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus
title_fullStr Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette–Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus
title_full_unstemmed Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette–Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus
title_short Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette–Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus
title_sort infection of an axillo-bifemoral bypass graft following intravesical bacillus calmette–guerin (bcg) immunotherapy for urothelial cancer due to mycobacterium bovis and staphylococcus aureus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850222/
https://www.ncbi.nlm.nih.gov/pubmed/31723689
http://dx.doi.org/10.1016/j.jctube.2016.09.001
work_keys_str_mv AT desimonedanielc infectionofanaxillobifemoralbypassgraftfollowingintravesicalbacilluscalmetteguerinbcgimmunotherapyforurothelialcancerduetomycobacteriumbovisandstaphylococcusaureus
AT tandeaaronj infectionofanaxillobifemoralbypassgraftfollowingintravesicalbacilluscalmetteguerinbcgimmunotherapyforurothelialcancerduetomycobacteriumbovisandstaphylococcusaureus